RxDoctor Payments Data

Uhronda Reel, APRN

Psychiatric/Mental Health · Little Rock, ARNPI 1922315613

Payments from drug & device makers

$843in general payments, 2019–2025

Across 30 payments — averaging $28.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$192
  • Otsuka America Pharmaceutical, Inc.$164
  • Neurocrine Biosciences, Inc.$157
  • AbbVie$115
  • Johnson & Johnson$78
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$61
  • plus $76 from 3 others

What the payments were for

  • Food & beverage$843100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$843 in reported general payments places this provider in the 50th percentile of 359 psychiatric/mental health providers in Arkansas.

See all psychiatric/mental health providers in Arkansas

Medicare billing

Part B allowed, 2024
$10,815
Medicare patients
72
Services billed
142

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega TrinzaPaliperidone Palmitate25$222,907
Invega SustennaPaliperidone Palmitate46$146,987
Abilify MaintenaAripiprazole32$92,178
VraylarCariprazine Hcl35$49,874
RexultiBrexpiprazole16$26,503
Haloperidol Decanoate170$11,289
Paliperidone ErPaliperidone65$9,491
Bupropion XlBupropion Hcl220$4,126
Trazodone Hcl325$2,969
Quetiapine Fumarate187$2,869
Lurasidone Hcl35$2,850
Aripiprazole110$2,841
Buspirone Hcl203$2,527
Fluphenazine Decanoate16$2,497
Benztropine Mesylate166$2,480

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Trinza, Invega Sustenna$78$369,89471 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$164$118,68248 claims
AbbVieVraylar$115$49,87435 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 359 psychiatric/mental health providers in Arkansas.

Other psychiatric/mental health in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →